COMMUNIQUÉS West-GlobeNewswire
-
Wesley Pharmaceuticals Expands Longevity Portfolio with Launch of Three Essential Injectable Formulations
23/06/2026 -
Fieldstone Bio, TerraCore, and MIT Awarded U.S. Department of Energy Contract to Accelerate Critical Mineral Discovery
23/06/2026 -
Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board
23/06/2026 -
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
23/06/2026 -
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
23/06/2026 -
The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH
23/06/2026 -
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
23/06/2026 -
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
23/06/2026 -
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
23/06/2026 -
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
23/06/2026 -
TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
23/06/2026 -
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
23/06/2026 -
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
23/06/2026 -
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
23/06/2026 -
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
23/06/2026 -
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
23/06/2026 -
Persephone Biosciences’ Science-Backed Infant and Toddler Synbiotics Now Available on Amazon
23/06/2026 -
ApolloMD Welcomes 2026 Emergency Medicine Administrative Fellows and Opens Applications for Next Class
23/06/2026 -
Integra LifeSciences Announces Key Executive Appointments
23/06/2026
Pages